Jounce Therapeutics Ownership

Jounce Therapeutics has a total of 52.64 Million outstanding shares. The majority of Jounce Therapeutics outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Jounce Therapeutics to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Jounce Therapeutics. Please pay attention to any change in the institutional holdings of Jounce Therapeutics as this could imply that something significant has changed or is about to change at the company. Also note that almost six hundred ninety-four thousand seven hundred eighty-nine invesors are currently shorting Jounce Therapeutics expressing very little confidence in its future performance. Some institutional investors establish a significant position in stocks such as Jounce Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Jounce Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.